Impact International Conferences welcomes you to join and share your research findings at Innovate Neurology 2019 in Dubai, UAE, Nov 12-13, 2019.
We cordially invite all
researchers, business professionals, and industry/academia representatives to Impact
Neurology 2019 where we will update the community as to the latest trends in
research, business strategies, current innovations and the latest technologies
relevant to the Neurology and Psychiatry community. Join us and share your
research findings with professionals from around the globe through thought provoking
Keynote lectures, Oral presentations, Video talks and Poster presentations.
Impact provides an excellent opportunity for the
business delegates from Medical devices companies and the Pharma Industry to
exhibit their products to an international audience.
The Summit will focus on the
theme “Exploring the innovations in Neurology & Encephalon Disorders”.
Objective
Impact Neurology 2019 has the
goal of filling the prevailing gaps in the transformation of research from
Neuro surgical industry, Neurology, psychiatry to products that can benefit
mankind. We hope to facilitate this
transformation via face to face meetings between research scientists and
business professionals in order to promptly develop solutions to roadblocks
that exist when basic research findings are translated to practical
applications.
Scientific Sessions
Impact Neurology 2019 will encompass presentations of recent
research findings with the objective of research and recovery from neurological
disorders and Neuron infectious diseases that will benefit world health. The
root motif of our conference is “Exploring the innovations in Neurology &
Encephalon Disorders” and will cover a broad area of topics that will be of
interest to basic and translational research scientists, surgical business
executives and scientists and surgeons entrepreneurs
Participants
Impact Neurology 2019 is an
outstanding event designed for CEO’s, Directors, CSO’s, Basic/Translational
Research Scientists, Industry Researchers, Business Professionals and Neurology
and surgery investors.
Founding Director Cell Therapeutics Pty Ltd
Southern Federal University
Universiti Kebangsaan Malaysia
National Institutes of Health
GALLY International Biomedical Research & Consulting LLC
Track 1: Brain Diagnosis
The diagnosis of the brain can
take many different exceptional forms and has been given many different
extraordinary names. It affects 1 in 6 people's lives and costs more than $1
trillion every year in medical expenses. There are 10 million people living in
the UK who have neurological conditions that have a significant impact on their
quality of life. The most common neurological conditions in the UK are
epilepsy, stroke, dementia, headache, and dementia. It was anticipated that
there would be a lifetime possibility of the brain and other valuable fearful
devices expanding. Within the UK, the prevalence of cancer is 1 in 133 for men
and 1 in 185 for women. The goal of this consultation is to identify the Root
Causes, Genesis, Origin, and Source of various types of Brain Issues.
Track 2: Brain Injury and Rehabilitation
A brain injury is a disturbance
or issue with the normal functioning of the mind that may be caused by a blow,
bump, or jolt to the head, by the head suddenly and violently colliding with
anything, or by something entering the cranium and entering the brain tissue.
Rehabilitation is a strict set of
treatments intended to improve a person's ability to function and reduce their
level of disability in the context of their surroundings. Depending entirely on
a person's ability to participate in a rehabilitation programme, there are many
different rehabilitation options.
Track 3: Electroconvulsive Therapy
While the patient is under
general anaesthetic, regulated electric currents are sent across the brain
during the ECT process. This results in a brief, controlled seizure that
changes the brain's neurons and molecules. It is most frequently used to treat
severe melancholy, depression, and psychosis when other treatments have failed.
ECT is also taken into consideration as a therapy option in some cases of
treatment-resistant bipolar illness.
Track 4: Neurological disorders
While the patient is under
general anaesthetic, regulated electric currents are sent across the brain
during the ECT process. This results in a brief, controlled seizure that
changes the brain's neurons and molecules. It is most frequently used to treat
severe melancholy, depression, and psychosis when other treatments have failed.
ECT is also taken into consideration as a therapy option in some cases of
treatment-resistant bipolar illness.
Track 5: Vagus Nerve Stimulation (VNS)
The vagus nerve, which transmits
signals to regions of the brain that regulate sleep and mood, is stimulated
with electrical impulses by VNS using a pulse generator that is almost the size
of a stopwatch and inserted in the upper left side of the chest. Epilepsy, as
well as other medical problems including sorrow, can be treated with VNS.
The FDA has approved VNS for the
treatment of depression that is difficult to treat, sorrow that doesn't get
better despite taking four different drugs, or ECT.
Track 6: Neuro-oncology & Brain Tumors
The study of brain and medulla
spinalis sequence neoplasms, such as astrocytomas, gliomas, glioblastomas
multiforme, ependymomas, pontine gliomas, and brain stem tumours, is known as
neuro oncology. Gliomas of the brainstem and pons, glioblastoma multiforme, and
high-grade (fantastically anaplastic) Astrocytoma are some of the worst types
of malignant brain cancer. Untreated survival in these cases typically amounts
to only a few months, and survival with modern radiation and chemotherapy
treatments may also increase that point from roughly a year to a year and a
half, probably or more, depending on the patient's condition, immune function,
treatments used, and the specific type of malignant brain tumour.
Track 7: Pediatric Neurology
Paediatric neurology, often known
as child neurology, is a specialised area of medicine that deals with the
diagnosis and treatment of neurological conditions in newborns, babies,
children, and adolescents. Child neurology covers illnesses and issues that
affect persons in certain age groups with the spinal cord, brain, peripheral
nervous system, autonomic nervous system, muscle mass, and blood vessels.
Track 8: pathophysiology of Brain Disorders
When the brain or the way it
functions is harmed or disrupted after a person is born, there is a brain
disorder. A damaged brain will alter memory, feeling, and occasionally even
personality. It can happen as a result of trauma such as concussion, lack of
oxygen, assault, falls, accidents, and other trauma that results in degenerative
diseases, brain tumours, Alzheimer's disease, and other dementias. Disorder
often has little effect on intelligence, while there may be cognitive
abnormalities such memory, focus, and attention issues. The civilization is
thought to be seriously affected by brain illnesses.
Track 9: Deep Brain Stimulation (DBS)
The FDA approved Deep Brain
Stimulation (DBS) for use in treating obsessive-compulsive disorder (OCD) even
though it was originally developed to lessen Parkinson's disease-related
tremors. Major depression and Tourette's syndrome are currently being treated
using DBS. The usefulness and safety of DBS for mental health remain uncertain
and its usage is heavily experimental.
Track 10: Neuropharmacology
A field of study known as
neuropharmacology may focus on medications that have an impact on the nervous system.
It is concentrated on the development of substances that may help people with
neurological or psychiatric disorders. As a result, this field necessitates a
thorough understanding of how the systema nervosum operates due to the manner
that each medicine affects neuronal circuits, changes cellular activity, and
ultimately affects how an organism behaves. Drugs that affect nervous
system-regulated activities are the focus of neuropharmacology, which uses
neural control to repair various functional imbalances in the body. The systema
nervosum is divided into several sections, including the peripheral systema
nervosum, which consists of somatic, sympathetic, and parasympathetic nerves
and ganglia, and the central systema nervosum, which includes the brain and
consequently the medulla spinalis. To activate or deactivate impulse
transmission or to activate effector processes at brain-effector cell
junctions, neurotransmitters act at synapses, or neural junctions.
Track 11: Brain Cancer & Tumors
Brain cancer is a condition where
cancer cells (malignant cells) develop in the brain tissue (brain cancer). A
tumour is a mass of cancerous tissue that develops from cancerous cells and
impairs brain activities like memory, feeling, and other typical bodily
functions. Malignant tumours are those made mostly of cancerous cells, and
benign tumours are those made primarily of non-cancerous cells. Primary brain
tumours are those that form from brain tissue, whereas metastatic or secondary
brain tumours are those that have spread from other parts of the body to the
brain. Neurofibromatosis, tuberous sclerosis, and a few other hereditary
genetic disorders may only account for roughly 5% of brain tumours.
Track 12: Psychology and Neuroscience
Psychology Cognitive psychology
and brain technology are two of the most in-demand and versatile areas of
mental knowledge in the modern world. Every career has a fascinating passion in
how the mind functions. Engineers, scientists, judges, public health and safety
officials, architects, and picture designers are just a few of the people who
need to learn more about how the brain processes information. Their research
and the subsequent programmes have evolved into a crucial component of how
institutions, businesses, and enterprises operate and flourish. Cognitive
psychologists are looking for solutions in scientific contexts to issues
relating to human intellectual methods, such as Alzheimer's disease, speech
issues, memory loss, and sensory or notion difficulties.Tuberous sclerosis,
neurofibromatosis, and a few more.
Track 13: Mental Disorder / Mental illness / Psychiatric Disorders
Mental disorders are typically
defined as a variety of means of a person's behaviour, feelings, perceptions,
or thoughts. This may be connected to particular brain functions or regions,
typically in a social setting. One aspect of intellectual fitness is an
intellectual disorder.
Treatments are offered by means
of a variety of intellectual fitness specialists. Important treatment options
include psychotherapy and psychiatric medications. Changes in behaviour, social
interventions, peer support, and self-help are further treatments. There is
likely involuntary detention or a remedy in a small percentage of situations.
It had been demonstrated that prevention programmes reduced depression. There
are numerous discrete intellectual disease subtypes, as well as numerous
distinct aspects of human behaviour and character that might become disordered.
Track 14: Neuroinformatics and Computational Neuroscience
Clinical data regarding the most
experimental information, ontologies, metadata, analytical tools, and
computational designs of the neural system are all referred to as
neuroinformatics. Experiments and experimental circumstances pertaining to the
genetic, molecular, structural, cellular, network, and behavioural levels in
all species and configurations in both the regular and disordered states make
up the majority of the information.
From a computational standpoint,
neuroinformatics examines data processing through fearful structures.
Philosophy, computer technology, and informatics are the three main foundations
of neuroinformatics.
The field of study known as
computational neuroscience uses mathematical tools and theories to study how
the mind works. It may also include numerous techniques from physics, computer
technology, and electrical engineering in order to understand how the concerned
device processes information. A branch of theoretical neuroscience called
computational neuroscience uses computer simulations to verify and correct the
mathematical hypotheses.
Track 15: Human Brain Mapping
The study of the anatomy and
characteristics of the brain and spinal cord using imaging,
immunohistochemistry, molecular and optogenetics, stem cell and cell biology,
engineering, neurophysiology, and nanotechnology is specifically described as
brain mapping.
The development and enhancement
of photo capture, representation, analysis, visualisation, and interpretation
methodologies are essential to the ongoing evolution of brain mapping
techniques. The middle of the mind mapping's mapping component is where
functional and structural neuroimaging is located.
Track 16: Excitotoxic cell damage
Excitotoxicity refers to the
pathological process whereby glutamate or a related excitatory amino acid
damages and kills nerve cells under conditions such those that result from
prolonged exposure. This happens when the excitatory neurotransmitter
receptors, such as those for N-methyl-D-aspartate (NMDA) or AMPA, are overactive.
Such excitotoxic neuronal death may occur as a byproduct of brain, spinal cord,
or other injuries or injury linked to a number of human disease conditions. The
neuronal cell death associated with neurodegenerative diseases has been
explained by a number of mechanisms, including accumulation of oxidising free
radicals, impairment of mitochondrial function, activation of apoptotic
programmes, and elevation of intracellular calcium.
Day-1: Nov 12, 2019 | ||
---|---|---|
program time | program session | |
09:00-09:30 | Registrations | |
09:30-10:00 | Inauguration Ceremony | |
10:00-10:45 | Keynote Session I | |
10:45-11:00 | Refreshment Break | |
11:00-11:45 | Keynote Session II | |
11:45-12:00 | Refreshment Break | |
12:00-14:45 | Break Out Session I | |
14:45-15:00 | Refreshment Break | |
15:00-18:00 | Break Out Session II |
Day-2: Nov 13, 2019 | ||
---|---|---|
program time | program session | |
10:00-10:45 | Keynote Session III | |
10:45-11:00 | Refreshment Break | |
11:00-13:00 | Break Out Session III | |
13:00-13:15 | Refreshment Break | |
13:15-15:15 | Poster Presentations | |
15:15-15:30 | Refreshment Break | |
15:30-17:30 | Break Out Session IV | |
17:30-18:30 | Closing Ceremony |